Rubin Jonathan 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-03-05$33.05/sh−314$10,378→ 10,789 total - Tax Payment
Common Stock
2025-03-05$33.05/sh−577$19,070→ 10,212 total - Tax Payment
Common Stock
2025-03-05$33.05/sh−577$19,070→ 9,635 total
Footnotes (1)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units.